Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB: FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce that Mr. Sheldon Inwentash, Dr. Eugene Dubossarsky and Mr. Antanas Guoga have joined its newly created Initial Coin Offering (ICO) Advisory Board for the pending launch of its Citizen Green Token.
Mr. Inwentash is chairman and chief executive officer of ThreeD Capital Inc., a Toronto-based venture capital firm specializing in investments in blockchain, cryptocurrencies, A.I. and junior resources. He has a track record of investing in early stage companies that grow to become large successful acquisition targets and has recently refocused his investment strategy to include new and emerging sectors of blockchain and cryptocurrencies.
Dr. Dubossarsky holds a Ph.D.in Machine Learning (Neural Networks) and is the Chief Data Scientist at AlphaZetta, a global analytics consultancy. As a consultant, he advises businesses with data science strategy including advanced methods to improve data science performance and deliver more measurable value. He specializes in applying data science to an entrepreneurial setting, financial trading and online start-ups, and has worked with numerous cryptocurrency companies.
Mr. Antanas Guoga, or better known as “Tony G”, is a poker player, entrepreneur, politician and an expert in cryptocurrencies and blockchain. He is currently Lithuania’s member of the European Parliament and a ICO special advisor to Bankera, which is one of the largest ICOs on record with a raise of over EUR46 million. His involvement in other blockchain and cryptocurrency success includes SpectroCoin, a cryptocurrency exchange that provides payment processing and other financial services, and the recently-announced online cryptocurrency poker room CoinPoker.
“I am extremely delighted to have such incredible individuals joining the ICO Advisory Board, helping to provide the strength to guarantee to the success of our ICO,” said Brad Moore, CEO of GCAC. “Rarely has there been such a talented and skilled group, all with multiple levels of engagement with GCAC. Our ICO and the Citizen Green Coin is promising to become an industry game changer, not only in blockchain and cryptocurrency, but also in helping people around the world people use medical cannabis in a safe and smart way. I look forward to working alongside Sheldon, Eugene and Tony G to shape the future of GCAC and create value for our shareholders.”
GCAC is finalizing the launch of its own initial coin offering, Citizen Green Tokens, as the basis of a medical cannabis loyalty program. The Citizen Green Token is part of Citizen Green data platform, the world’s first end to-end data aggregation and user delivery system for the medical cannabis industry. Digital tokens and blockchain will play an important role on providing a value based, trusted environment where users can share information and earn tokens for their participation.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-5619091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications Canada & Europe
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Corporate Communications United States
Hayden IR
Telephone: 1.917.658.7878
Email: hart@haydenir.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FSE:2FA, OTCQB: FUAPF) for an Investor Presentation. 

Source: www.thenewswire.com


Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less